Update
$TFF Pharmaceuticals(TFFP.US$ TFF Pharmaceuticals Announces Additional Positive Data From the Tacrolimus Inhalation Powder (TFF Tac) Phase 2 Trial Following Oral Presentation at the Ishlt 44TH Annual Late Breaking Clinical Science Abstract Sessions. TFF Pharmaceuticals Inc: Successful Transition of Eight of Eight Patients From Oral Tacrolimus to TFF Tac
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Trytosaveabit OP : TFF Pharmaceuticals Inc: Plans to Open an Ind in US to Explore Use of TFF Tac Early Post-Transplant in Preparation for a Registrational Trial